Project Grant R21AI189358
Award Date 8/12/25
Completion Date 7/31/27
Dollars Obligated $450K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $186,332 to Vanderbilt University Medical Center to conduct research on severe cutaneous adverse drug reactions, specifically Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) associated with vancomycin treatment. The goal is to discover genetic, multi-omic, and other risk factors that interact with the HLA-A*32:01 allele to...
- This federal Project Grant award of $873,716.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development and pilot testing of the CARE, Review, Assessment and Feedback Tool (CRAFT) intervention. The CRAFT-IAR (CRAFT Bundle in Acute Respiratory Infections) study aims to adapt the CRAFT tool to provide automated feedback on patient outcomes and clinical prescribing processes in...
- This $859,083 Project Grant, awarded on August 21, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the Southeastern HIV Implementation Science Hub led by Vanderbilt University Medical Center (VUMC). The Hub aims to enhance the sustained implementation of evidence-based HIV diagnosis, treatment, and prevention services among academic, community, and clinical partners in the southeastern U.S. The project will...
- This $658,019 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of the award is to establish a Rigorous, Rapid, and Relevant Evidence Adaptation and Implementation (R3EDI) Consultation Hub to support the Ending the HIV Epidemic (EHE) initiative. The R3EDI Hub will provide technical assistance, training resources, and consultation support to EHE...
- This $300,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a GMP-compliant E. coli dihydrofolate reductase (EDHFR) vector. This vector will be used to monitor the biodistribution and trafficking of investigational chimeric antigen receptor (CAR) T cell therapies through positron emission tomography (PET) imaging. The goals are to provide a...
- This Project Grant award of $481,250 from the National Institute of Allergy and Infectious Diseases (NIAID, CFDA 93.855 Allergy and Infectious Diseases Research) supports research to understand the mechanisms of human rotavirus (RV) egress and infection in association with extracellular vesicles (EVs). The project aims to characterize how RV interacts with EVs derived from human colonic epithelial cell lines (Caco-2 and HT29) to facilitate virus release, immune evasion, and enhanced infection of...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports the creation, evaluation, and sharing of synthetic data for multinational HIV cohorts. The $873,570 award to Vanderbilt University Medical Center (VUMC) aims to adapt and apply state-of-the-art artificial intelligence methods to generate synthetic data that closely resembles data from two large international HIV cohorts - the Caribbean, Central and...
- This $108,115 Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), supports comprehensive characterization of lentiviral vector (LVV) integration and impact on host cell biology using novel genomic technologies. The research aims to provide a deeper understanding of LVV integration patterns and cellular transformation, which has emerged as a critical safety...
- The University of Chicago received a $126,435 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to pilot the implementation of electronic patient-reported sexual health data into electronic medical records (EMRs) to identify individuals who would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. The project, titled "INFOHIV: Clinical Informatics for Optimizing HIV Prevention and...
- The federal Project Grant award of $3,436,588.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The award supports research to investigate the role of the TLE3 transcription cofactor in regulating the function and persistence of CD8+ T cells during chronic viral infections and cancer. The research aims to molecularly reconstruct the T cell exhaustion process and identify therapeutic...